Get the Stockscreener App
2.85
1.72%
-0.05
Xbiotech Inc stock is traded at $2.85, with a volume of 34,847.
It is down -1.72% in the last 24 hours and down -10.09% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$2.90
Open:
$2.85
24h Volume:
34,847
Relative Volume:
0.39
Market Cap:
$86.89M
Revenue:
$4.01M
Net Income/Loss:
$-38.53M
P/E Ratio:
-2.2619
EPS:
-1.26
Net Cash Flow:
$-32.27M
1W Performance:
-0.70%
1M Performance:
-10.09%
6M Performance:
-17.63%
1Y Performance:
-60.96%
1-Day Range:
$2.815
$2.90
1-Week Range:
$2.79
$2.92
52-Week Range:
$2.50
$8.32
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.85 | 88.41M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
Should I hold or sell XBiotech Inc. stock in 2025Earnings Report Planner For 2025 - jammulinksnews.com
Published on: 2025-08-02 01:35:08 - Newser
XBiotech Inc. (NASDAQ:XBIT) Short Interest Up 452.0% in July - MarketBeat
Long term hold vs stop loss in XBiotech Inc.Free Low Capital High Return Stock Plans - Newser
Applying Elliott Wave Theory to XBiotech Inc.Retirement Investment Outlook and Return Summary - Newser
XBiotech (NASDAQ:XBIT) Stock Price Passes Below Fifty Day Moving AverageShould You Sell? - MarketBeat
What data driven models say about XBiotech Inc.’s futureFree Reliable Chart-Based Trade Entries - Newser
Using AI based signals to follow XBiotech Inc.Entry Confirmation Based on Volatility Analysis - Newser
Can a trend reversal in XBiotech Inc. lead to recoveryProven Trading System with Consistent Gains - Newser
Does XBiotech Inc. fit your quant trading modelFree Entry Plan for Oversold Reversal Stocks - Newser
How does XBiotech Inc. generate profit in a changing economyStock Market Data Feed For Consistent Profits - jammulinksnews.com
Why is XBiotech Inc. stock attracting strong analyst attentionEarnings Report Opportunities To Watch Now - jammulinksnews.com
What makes XBiotech Inc. stock price move sharplyTop Growth Target Finder To Watch Now - jammulinksnews.com
XBiotech Inc. Stock Support and Resistance Levels You Should KnowFree Swing Trading Entry Point Signals - Newser
Why XBiotech Inc. stock attracts strong analyst attentionAlpha Focused Technical Trade Signals Gain Attention - metal.it
Leading vs lagging indicators on XBiotech Inc. performanceLong Term Equity Screener with Safety Metrics - Newser
Institutional scanner results for XBiotech Inc.Trend Confirmation Scanner with Entry Focus - Newser
How XBiotech Inc. stock performs during market volatilityFree Fast Return Equity Trade Forecast - Newser
What is XBiotech Inc. company’s growth strategyNavigate market shifts with confidence - jammulinksnews.com
What are analysts’ price targets for XBiotech Inc. in the next 12 monthsDiscover hidden gems in the stock market - jammulinksnews.com
What markets is AMH.PRH expanding into Is XBiotech Inc. stock a good long term investment optionAchieve rapid financial growth with expert picks - jammulinksnews.com
When is XBiotech Inc. stock expected to show significant growthAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
Is XBiotech Inc. a growth stock or a value stockBoost your returns with professional guidance - jammulinksnews.com
How strong is XBiotech Inc. company’s balance sheetUnmatched profit growth - jammulinksnews.com
Is XBiotech Inc. stock overvalued or undervaluedBuild wealth with high-performing stocks - jammulinksnews.com
Is it the right time to buy XBiotech Inc. stockPowerful market insights - jammulinksnews.com
Published on: 2025-07-27 22:45:10 - jammulinksnews.com
XBiotech Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree High-Profit Stock Picks - Newser
How Resilient Is XBiotech Inc. Stock During Economic DownturnsROI Driven Alerts - Newser
XBiotech (NASDAQ:XBIT) Stock Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
XBiotech Inc. Stock Analysis and ForecastHigh-velocity gains - PrintWeekIndia
Is XBiotech Inc. a good long term investmentExplosive earnings growth - PrintWeekIndia
Is XBiotech Inc. stock overhyped or has real potentialFree Stock Chart Pattern Guide - jammulinksnews.com
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):